[1]
Bertelli G(2016)Bevacizumab for ovarian cancer at high risk of progression: Reproducibility of trial results in 'real-world' patients. Anticancer Research 36 4947-4950
[1]
Bertelli G(2016)Bevacizumab for ovarian cancer at high risk of progression: Reproducibility of trial results in 'real-world' patients. Anticancer Research 36 4947-4950